Sundia MediTech Co., Ltd.
Recently merged with United PharmaTech and formed alliance with HD Biosciences, Sundia offers broad and integrated services of custom organic synthesis, medicinal chemistry, process chemistry, APIs manufacturing under cGMP or non-cGMP, bioassay, and in vitro & in vivo PK studies.
Sundia has successfully established collaborations with over 45 client companies in North America, Europe, and Japan. Its professional team possesses talents from organic synthesis, medicinal chemistry, process chemistry, biology, to business management, and law.
Sundia's management team members have received advanced degrees or training and have extensive working / management experiences in North America. Its research team comprises over 200 scientists, among which 16% are Ph.D.'s; 47% MS's; and 37% BS's.